Acute renal transplant rejection

Last revised by Yuranga Weerakkody on 10 Jan 2024

Acute renal transplant rejection is a renal transplant complication that occurs within <5-7 days of the placement of the transplant. Although part of a spectrum of closely-related rejection disorders, the term is meant to distinguish this type of rejection from chronic renal transplant rejection, which is slower and progressive.

Traditionally, acute renal transplant rejection has been divided into three types

  • hyperacute (minutes-hours, often in the operating room)

    • this type of rejection is rarely imaged

  • acute (5-7 days)

  • accelerated acute (5-7 days)

There has been an evolution in understanding about acute transplant rejection, however, and some of the features blend with chronic transplant rejection. An updated set of terminology describes categories based on the underlying reason for the rejection, as found at biopsy.

Antibody-mediated rejection: 

  • active 

  • chronic active

  • chronic

T-cell mediated rejection

  • acute

  • chronic active

The original terms still have clinical significance, however, and are used informally in discussing renal allograft dysfunction.

Renal transplant rejection is not a radiologic diagnosis. It relies on histologic evaluation in combination with molecular, serologic, and clinical parameters. 

There are two main forms: antibody-mediated rejection and T-cell mediated rejection.

Renal transplant ultrasound is usually the first line imaging modality for evaluation of a renal transplant. Some findings suggest transplant dysfunction, but there are no sonographic findings specific for rejection.

The current role of imaging is to evaluate potential renal transplant dysfunction with a combination of grayscale and color Doppler findings, not to diagnose rejection directly. Rejection is diagnosed on biopsy.

ADVERTISEMENT: Supporters see fewer/no ads